Serum sulfhydryl levels in rheumatoid patients treated with haloperidol

Scand J Rheumatol. 1980;9(4):225-8. doi: 10.3109/03009748009112352.


Six months of haloperidol treatment significantly increased the serum sulfhydryl (SH) levels in all 12 rheumatoid arthritis (RA) patients studied and significantly decreased the PIP joints technetium index (Tc-index), erythrocyte sedimentation rate (ESR) and joint count. These findings suggest a specific antirheumatic activity of haloperidol in the RA patients.

MeSH terms

  • Adult
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / drug therapy*
  • Blood Sedimentation
  • Haloperidol / therapeutic use*
  • Humans
  • Middle Aged
  • Serotonin / blood
  • Sulfhydryl Compounds / blood*
  • Technetium


  • Sulfhydryl Compounds
  • Serotonin
  • Technetium
  • Haloperidol